These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9432697)

  • 1. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
    Weisser M
    Praxis (Bern 1994); 1997 Oct; 86(43):1708-10. PubMed ID: 9432697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
    Hester EK; Peacock JE
    AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine-associated myopathy.
    Paradis J; Calis KA
    Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
    Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
    Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine-induced lactic acidosis with acute pancreatitis and myopathy: Lethal and rare complications.
    Mahto SK; Gupta PK; Taneja RS; Singh A
    Indian J Pharmacol; 2018; 50(4):212-214. PubMed ID: 30505059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral nerve diseases and myopathies associated with HIV infection].
    Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
    Scruggs ER; Dirks Naylor AJ
    Pharmacology; 2008; 82(2):83-8. PubMed ID: 18504416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No adverse effects in infants following short-course zidovudine.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.
    Foli A; Lori F; Maserati R; Tinelli C; Minoli L; Lisziewicz J
    Antivir Ther; 1997 Jan; 2(1):31-8. PubMed ID: 11322264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug research shows easier dosing, new combinations are making gains.
    AIDS Alert; 1998 Apr; 13(4):37-9. PubMed ID: 11365139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe anemia in the framework of zidovudine treatment in HIV disease].
    Kis L; Heitzmann F; Keusch G; Möddel M
    Praxis (Bern 1994); 2006 Jan; 95(4):119-22. PubMed ID: 16485608
    [No Abstract]   [Full Text] [Related]  

  • 18. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.